The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17
- PMID: 31281851
- PMCID: PMC6594276
- DOI: 10.1155/2019/5237371
The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17
Abstract
Background: To examine the association between morbid events and metabolic syndrome (MS) in patients with type 2 diabetes mellitus (T2DM).
Methods: A prospective, longitudinal, multicenter study was conducted at 13 community health centers associated with Beijing Tongren Hospital. From 2008 to 2015, there have been 3,525 T2DM patients being managed based on the Chinese guideline for T2DM. The morbid events included macrovascular events, diabetic kidney disease, ophthalmologic events, cancer, and all-cause death.
Results: At baseline, there were 2,708 people with MS and 817 without MS. After a seven-year management, there were 351 (12.96%) events in MS people and 74 (9.06%) events in people without MS (p = 0.003). The prevalence of macrovascular events (6.06%) was much higher in MS people than in people without MS (3.79%, p = 0.013). Cox regression analysis showed an association between MS and morbid events even after adjusting for confounding variables (adjusted hazard ratio = 1.44). MS was also associated with macrovascular events (adjusted hazard ratio = 1.96). The occurrence of morbid events and macrovascular events was increased when the numbers of metabolic abnormalities were 1, 2, 3, and 4 (p < 0.001). There was no continuously statistically significant difference in the cumulative prevalence of morbid events between patients with MS and patients without MS during the first five years. However, after six or seven years, the cumulative prevalence of morbid events in patients with MS was continuously significantly higher than that in patients without MS (11.00% vs. 8.20%, 12.96% vs. 9.06%, p < 0.05).
Conclusions: T2DM with MS had higher incidence of morbid events, especially cardiovascular events, even after integrated management. The occurrence of morbid and macrovascular events increased as the number of metabolic abnormalities increased. MS was associated with increased risk of morbid events by 44% and macrovascular events by 96%. It would take at least six years to observe the association between MS and morbid events in T2DM.
Figures
Similar articles
-
Influence of educational attainments on long term glucose control and morbid events in patients with type 2 diabetes receiving integrated care from 15 China urban communities: The Beijing Community Diabetes Study 11.Prim Care Diabetes. 2015 Dec;9(6):473-81. doi: 10.1016/j.pcd.2015.03.005. Epub 2015 Apr 10. Prim Care Diabetes. 2015. PMID: 25865852
-
ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women.Endocrinol Diabetes Nutr (Engl Ed). 2019 Oct;66(8):502-511. doi: 10.1016/j.endinu.2019.03.019. Epub 2019 Jun 8. Endocrinol Diabetes Nutr (Engl Ed). 2019. PMID: 31182348 English, Spanish.
-
Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus among Chinese: the Beijing longitudinal study of aging.Lipids Health Dis. 2021 Jul 17;20(1):71. doi: 10.1186/s12944-021-01499-5. Lipids Health Dis. 2021. PMID: 34273996 Free PMC article.
-
Uric acid and diabetes: Is there a link?Curr Pharm Des. 2013;19(27):4930-7. doi: 10.2174/1381612811319270016. Curr Pharm Des. 2013. PMID: 23278493 Review.
-
Rubrometabolic Syndrome.Minerva Endocrinol (Torino). 2023 Mar;48(1):59-75. doi: 10.23736/S2724-6507.20.03353-2. Epub 2020 Dec 17. Minerva Endocrinol (Torino). 2023. PMID: 33331741 Review.
Cited by
-
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.Intern Emerg Med. 2021 Jun;16(4):863-874. doi: 10.1007/s11739-020-02520-y. Epub 2020 Oct 20. Intern Emerg Med. 2021. PMID: 33083946 Free PMC article.
References
-
- Bhowmik B., Afsana F., Siddiquee T., et al. Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions. Journal of Diabetes Investigation. 2015;6(3):280–288. doi: 10.1111/jdi.12268. - DOI - PMC - PubMed
-
- Alberti K. G. M. M., Zimmet P. Z., WHO Consultation Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine. 1998;15(7):539–553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. - DOI - PubMed
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical